When liver disease becomes severe, the liver may no longer perform important functions properly. This stage is often referred to as advanced or end-stage liver disease. Patients may develop complications such as jaundice, fluid build-up, bleeding, confusion or worsening liver function.
At this stage, doctors need a clear and objective way to assess how urgently each patient may need a transplant. The MELD score helps measure the severity of liver disease using blood test results. It supports fair prioritisation on the transplant waiting list and also helps doctors explain the expected treatment journey. This article explains how the MELD score works, how it influences liver transplant allocation and what factors affect five-year survival after liver transplantation.
MELD stands for Model for End-Stage Liver Disease. It is a numerical score ranging from 6 to 40, calculated from routine blood tests, including serum bilirubin, creatinine, and INR, in updated versions, serum sodium. A higher MELD score indicates more severe liver dysfunction and a greater need for urgent medical care. The score is updated regularly and widely used to assess transplant urgency and support fair allocation of liver transplants.
The MELD score is the primary tool for stratifying patients by need. In transplant evaluation, the Meld score liver assessment helps clinicians decide who should be listed, when listing should occur, and how often a patient must be reassessed. Because the score uses objective laboratory data, it provides a consistent measure across patients and centres. As liver function declines, the score rises, signalling greater urgency for transplant.
The MELD score helps doctors determine which patients most urgently need a liver transplant. It ensures that donor organs are allocated fairly while taking into account several important medical factors.
The MELD score is an important part of the allocation process, but it is not the only factor doctors consider. A comprehensive clinical assessment helps ensure each donor liver is allocated to the most suitable recipient at the right time.
Liver transplant outcomes have improved considerably over the years due to advances in surgical techniques, immunosuppressive therapy and post-transplant care. As a result, five-year survival is now an important indicator of long-term transplant success. Reported survival rates generally remain favourable across leading transplant centres, although outcomes vary depending on the underlying liver disease, the patient's overall health and the timing of transplantation. A liver specialist in Mumbai can help explain what these survival figures mean based on an individual's condition.
Long-term outcomes after liver transplantation reflect more than the liver transplant score alone. Important factors include:
The first year after transplant requires close follow-up. Patients are monitored for rejection, infection, and side effects of immunosuppression (a reduction in the immune system's activation or efficacy). Over time, lifestyle plays an increasingly important role. Maintaining a healthy weight, avoiding alcohol, controlling blood pressure and blood sugar, and keeping up with vaccinations all contribute to long-term graft survival. Patients undergoing liver transplantation at Sir H. N. Reliance Foundation Hospital receives regular follow-up to monitor recovery, manage complications and support long-term transplant success.
Referral for transplant assessment should not be delayed once liver disease becomes advanced. Signs that warrant a transplant discussion include:
The MELD score plays a central role in determining liver transplant priority. It provides an objective assessment of liver disease severity and transplant urgency. However, long-term success depends on many factors beyond the MELD score. These include the underlying liver disease, donor organ quality, post-transplant care and medication adherence. Healthy lifestyle choices also support better long-term outcomes. Advances in transplant surgery and follow-up care have improved survival over the years. Timely transplant evaluation, structured follow-up, and multidisciplinary care at Sir H. N. Reliance Foundation Hospital helps improve long-term transplant outcomes.
Yes, in certain situations, patients with liver cancer within accepted criteria, or those with specific complications, may be granted exception points that allow listing despite a lower MELD score. Each case is reviewed individually by the transplant team. Certain patients with liver cirrhosis may develop complications such as intractable ascites, hydrothorax, or recurrent hepatic encephalopathy (HE), despite having a low or normal MELD score. These patients may also require a liver transplant.
Age alone is not a barrier to transplant, but overall fitness becomes more important with advancing years. Older recipients are carefully assessed for heart, kidney, and lung function before listing. Many older patients do extremely well after a transplant.
Stopping alcohol, treating underlying causes such as viral hepatitis, and managing nutrition can stabilise or even improve liver function in some patients. Improvements take time and may not reverse advanced cirrhosis, but they can change the disease trajectory.
Disclaimer:
This article is for general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified specialist or healthcare professional regarding any medical condition or treatment decision.
Medically Reviewed By: Dr. Akash Shukla, Director - Department of Hepatology, Sir H. N. Reliance Foundation Hospital.